Developer of ultrasonic systems for osteoporosis diagnostics,
bone assessment, bone age, balance assessment, local distribution
of medical devices and esthetics lasers.
Employees: 45
Market regions:
Europe, North and South America, Asia
Overview
The BeamMed Group is dedicated to building outstanding offerings
Click here to request more information, about this company (FOR COLLABORATION IN R&D. ONLY!)
Note - you have to be registered in this server to
request information. If you haven't done so
yet, please register in this server
Your requests will be forwarded to the developer, who
will contact you directly
You can also see the list of
documents you already requested more information about
of advanced medical solutions that improve care, treatment and
outcomes. "Sunlight Medical Ltd." Ultrasound operation and IP
rights were acquired by BeamMed on August 2006. (Sunlight Medical
Ltd. was established in 1995).
Leveraging the newest developments in proven technologies and its
extensive market experience, BeamMed designs, develops and
internationally high-quality, cutting edge medical devices for
assessing bone strength based on its proprietary quantitative
Ultrasound technologies. These best in class solutions, sold
under the internationally recognized Sunlight brand, offer proven
advantages in both accuracy and patient safety over solutions
that utilize conventional bone density measurement technologies.
In Israel, BeamMed is a leading distributor of medical devices
and equipment from leading companies worldwide, with specialties
in Medical Aesthetics and Urology technologies.
BeamMed innovative products are used by medical professionals in
thousands of clinics and hospitals around the world and the
products we distribute in Israel are among the most popular in
their fields. The success of BeamMed's products in their target
marketplaces is testament to their quality and efficacy, and
likewise it is the strongest proof of the value that BeamMed
brings to its partner and customer relationships.
BeamMed Ventures operates as the investment division of the
BeamMed Group, through which the company seeks to propel
promising Ultrasound-based technologies through advanced
development and into the market.
In its current operations and ongoing search for growth
opportunities, BeamMed is committed to bringing real clinical and
cost benefits to patients, medical professionals, hospitals, and
insurers. The company does this by identifying promising or
proven technologies and products that offer strong advantages
over alternative approaches. Applying its deep experience in
developing and selling medical devices, BeamMed develops new
innovations and take the technologies and products into new
markets throughout Europe, North and South America, Asia-Pacific,
and Israel.
